Personalized immune cell therapy tested for Tough-to-Treat uterine cancer

NCT ID NCT06481592

Summary

This study is testing a personalized cell therapy called lifileucel for women with advanced endometrial cancer that has stopped responding to standard treatments like chemotherapy and immunotherapy. Doctors will collect a patient's own tumor-fighting immune cells, grow large numbers of them in a lab, and then infuse them back into the patient to attack the cancer. The main goal is to see if this approach can shrink tumors and control the disease in patients who have few other options.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ENDOMETRIAL CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Allegheny Health

    RECRUITING

    Pittsburgh, Pennsylvania, 15524, United States

  • Augusta University

    RECRUITING

    Augusta, Georgia, 30912, United States

  • Avera Medical Group Oncology

    RECRUITING

    Sioux Falls, South Dakota, 57105, United States

  • Barbara Ann Karmanos Cancer Hospital

    RECRUITING

    Detroit, Michigan, 48201, United States

  • H. Lee Moffitt Cancer Center and Research Institute, Inc.

    RECRUITING

    Tampa, Florida, 33612, United States

  • Honor Health

    RECRUITING

    Phoenix, Arizona, 85016, United States

  • MD Anderson Cancer Center - U of Texas

    RECRUITING

    Houston, Texas, 77030, United States

  • Orlando Health

    RECRUITING

    Orlando, Florida, 32806, United States

  • Roswell Park Cancer Institute

    RECRUITING

    Buffalo, New York, 14203, United States

  • University of Oklahoma

    RECRUITING

    Oklahoma City, Oklahoma, 73117, United States

  • University of Southern California

    RECRUITING

    Los Angeles, California, 90007, United States

  • UofL Health - Brown Cancer Center

    RECRUITING

    Louisville, Kentucky, 40202, United States

Conditions

Explore the condition pages connected to this study.